Back

The effect of semaglutide once weekly on MACE and blood pressure by race and ethnicity: SUSTAIN 6 post hoc analysis

3 September 2019 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 7 - Pharmacotherapy of diabetes: from bench to bedside Antidiabetic Pharmacotherapy ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Cyrus Desouza

University Of Nebraska Medical Center, Omaha (United States of America)

6 More presentations in this session

Presentation thumbnail
Doctor S. Park (Illkirch, FR)
Abstract Slides
Presentation thumbnail
Doctor H. Kondo (Yufu City, JP)
Abstract
Presentation thumbnail
Doctor C. Parco (Ibbenbueren, DE)
Abstract
Presentation thumbnail
Mr J. Ghouse (Copenhagen, DK)
Abstract
Presentation thumbnail
Professor D. McGuire (Dallas, US)
Abstract

Access the full session

Session thumbnail
Poster Session 7 - Pharmacotherapy of diabetes: from bench to bedside

The Event

Event poster

ESC Congress 2019

3 September 2019 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Effects of once-weekly semaglutide on coronary outcomes in patients with type 2 diabetes mellitus with or at high risk for cardiovascular disease: insights from the SUSTAIN-6 trial
7 April 2022
thumbnail
Congress Presentation
Impact of ethnicity in outcomes of major cardiovascular events in adult patients with hypertension: a meta-regression analysis of 24 randomized trials
29 August 2025
thumbnail
Congress Presentation
Efficacy and safety of dapagliflozin in black, compared to white, patients with heart failure with reduced ejection fraction: Results from DAPA-HF
29 June 2021
thumbnail
Congress Presentation
Effect of glucagon-like peptide-1 receptor agonists on blood pressure: a systematic review and meta-analysis
4 April 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources